Kimberly-Clark (KMB)
NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-07-07
$114.74+1.53%
Close 2026-07-07 · 1-day change
Reading KMB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KMB free→NASDAQConsumer StaplesHousehold & Personal ProductsSnapshot 2026-07-07
Reading KMB? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track KMB free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a durable compounder with a focus on steady growth. The current thesis state is intact, supported by recent strong financial performance despite some sector headwinds.
The market currently prices KMB at a level that reflects a neutral valuation compared to peers. There is a slight expectations gap, indicating that while the stock is not considered cheap, it is justified given its recent performance.
KMB's fundamentals are likely to continue showing strength, as management is on track with priorities like growing organic sales and increasing adjusted earnings per share. However, there is a moderate risk due to the potential for guidance cuts in future earnings calls.
The thesis hinges on the performance of sector bellwethers like Procter & Gamble, Unilever, and Colgate-Palmolive. If these companies continue to perform well, it could provide a favorable backdrop for KMB, while any negative shifts could impact its trajectory.
Overall, KMB's position is supported by solid management execution and recent financial results, but it faces risks from sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The latest earnings beat supports the view that Kimberly-Clark can grow organic sales and increase adjusted earnings per share. However, concerns about a potential deal with Kenvue raise questions about the company's focus and its ability to maintain sales growth.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Why it matters: Changes in CFO can affect financial strategy. This can impact overall performance.
Confirms:Q2 2026 results show no negative impact. Financial performance remained strong despite the CFO transition.
Disproves:Q2 2026 results show a decline in financial performance. This is attributed to the CFO transition.
Why it matters: The CFO leaving could change financial strategy and reporting during a key time.
Confirms:Financial reports after the CFO left show no big changes or errors.
Disproves:Financial reports show problems or errors after the CFO left.
Why it matters: Finishing this will be a big step for Kimberly-Clark's growth plans.
Confirms:An official announcement will confirm that Kenvue has been bought.
Disproves:News of delays or rules stopping the deal from closing.
Why it matters: Updates on the Kenvue deal could affect Kimberly-Clark's growth plans and market position.
Confirms one read:Good news on the Kenvue deal shows synergies or growth potential.
Confirms the other:Bad news about the Kenvue deal raises concerns about costs or integration.
Why it matters: Ongoing sales growth shows strong demand for Kimberly-Clark's products. This supports management's goals.
Confirms:In Q2 2026, organic sales growth was over 2.5%. This matches management's growth goals.
Disproves:In Q2 2026, organic sales growth was below 2.0%. This shows possible demand weakness.
Why it matters: Adjusted EPS growth shows how well Kimberly-Clark is doing financially.
Confirms:In Q2 2026, adjusted EPS was above $1.70. This shows strong earnings.
Disproves:In Q2 2026, adjusted EPS was below $1.60. This may show profit problems.
Why it matters: A steady gross margin shows good cost control during inflation.
Confirms:Gross margin reported above 36% for Q2 2026.
Disproves:Gross margin reported below 35% for Q2 2026.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Double-digit growth in adjusted EPS shows strong financial health and good cost control.
Confirms:Adjusted EPS from continuing operations grows by 10% or more.
Disproves:Adjusted EPS from continuing operations grows less than 10%.